VIVAZEN® Urges Immediate Action on 7-OH as U.S. House of Representatives Examines End Needless Distribution of 7-OH Act
VIVAZEN®, the nation’s leading botanical wellness company, welcomed congressional scrutiny of 7-hydroxymitragynine (7-OH) as the House Energy and Commerce Subcommittee on Health holds a legislative hearing on H.R. 8000, the End Needless Distribution of 7-OH Act, introduced by Representative Gus Bilirakis (R-FL) and related illicit-drug legislation. The hearing underscores growing concern in Washington about 7-OH, as members of the subcommittee called on the Drug Enforcement Administration (DEA) to promptly move to schedule the synthetic, lab-made drug and protect consumers.
Groundbreaking Clinical Study Reveals Promising Evidence for VIVAZEN®’s Kratom Extracts
VIVAZEN® proudly announces the results of a pioneering 28-day clinical study evaluating the safety and tolerability of its proprietary kratom extracts.
VIVAZEN® Applauds Kentucky’s Leadership in Protecting Consumers from Synthetic 7-Hydroxymitragynine (7-OH)
VIVAZEN®, a leading botanical wellness company specializing in natural, full-spectrum kratom products, expressed strong support for Kentucky Governor Andy Beshear and Health and Family Services Secretary Dr. Steven Stack following the announcement that the state will move to classify isolated and concentrated forms of 7-hydroxymitragynine (7-OH) as Schedule I narcotics.
Vivazen® Reports Positive Results from Stress Relief Real-World Study*
Vivazen® today announced results from a 21-day at-home real-world study evaluating its Stress Relief* product, conducted in partnership with MoreBetter® and the Network of Applied Pharmacognosy (NAP). The study assessed participants' daily stress levels, mood, and quality of life before and during product use.
VIVAZEN® Applauds Florida’s Emergency Ban on Synthetic 7-OH, Reinforces Commitment to Safe, Natural Kratom
VIVAZEN®, a leading botanical wellness brand, today praised the Florida Attorney General’s emergency scheduling of synthetic 7-hydroxymitragynine (7-OH), calling the targeted action a public health win that protects consumers while preserving access to responsibly formulated kratom products.
VIVAZEN® and MoreBetter® Announce Landmark Real-World Evidence Study on Its Proprietary Extract, Highlighting the Power of Botanicals in Daily Wellness
VIVAZEN®, a trusted leader in botanical-based wellness products, proudly shares the results of a first-of-its-kind Real-World Evidence (RWE) study using its proprietary extract. The study was conducted in partnership with MoreBetter®, a leading real-world data and research platform. The study tracked the daily experiences of real users over 21 days and revealed statistically significant improvements in energy, focus, and productivity without the use of caffeine or stimulants.*
